Skip to main content
The Myeloid Network The Myeloid Network
  1. The Myeloid Network
  2. Seminars
  3. Past Seminars

Past Seminars

Recorded seminars will be posted here. Please note that some seminars might not be able to be posted.
  • Mikael Pittet, Ph.D.

    Mikael Pittet, Ph.D.

    November 13, 2025

    Myeloid Cells in Cancer

    Professor, Department of Pathology and Immunology, University of Geneva
    Director of the Translational Research Center in Oncohematology (CRTOH), University of Geneva
    Member, Ludwig Cancer Research, Lausanne Branch

    This seminar was not recorded. 
  • Nan Zhang, Ph.D.

    Nan Zhang, Ph.D.

    October 9, 2025

    Leveraging Myeloid Cell Activation in Metastatic Ovarian Cancer

    Assistant Professor, Molecular & Cellular Oncogenesis Program, Ellen and Ronald Caplan Cancer Center, The Wistar Institute
    Scientific Director, Imaging Facility, The Wistar Institute 

     

     
  • Florent Ginhoux, Ph.D.

    Florent Ginhoux, Ph.D.

    September 11, 2025

    Tissue Macrophage Heterogeneity

    Senior Principal Investigator, Singapore Immunology Network
    Laboratory Director, Institut Gustave Roussy
    Adjunct Visiting Associate Professor, Shanghai Institute of Immunology, Jiao Tong University, Shanghai, China
    Adjunct Associate Professor, Translational Immunology Institute, SingHealth and Duke-NUS, Singapore

    This seminar was not recorded. 

     
  • Renato Ostuni, Ph.D.

    Renato Ostuni, Ph.D.

    June 12, 2025

    Molecular and Spatial Control of Myeloid Cells in Cancer

    Associate Professor of Tissue Biology, Vita-Salute San Raffaele University, Milan
    Group Leader, San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Milan, Italy
    Principal Investigator, Epigenetics and Innate Immunity Laboratory
    European Research Council (ERC) Grantee – Starting, Consolidator, and Proof-of-Concept Grants
  • Sven Brandau, Ph.D.

    Sven Brandau, Ph.D.

    May 8, 2025

    Neutrophils and PMN-MDSC in Human Immuno-Oncology

    Professor of Tumor Immunology, University Hospital Essen
    Group Leader, West German Cancer Center, University Medicine Essen
    Chair, Graduate School for Biomedical Sciences (BIOME), University Duisburg-Essen
    Chair, UMESCIA Postdoctoral Training Network
  • Leila Akkar, Ph.D.

    Leila Akkar, Ph.D.

    April 10, 2025

    Unveiling Myeloid Cell Diversity in the Brain Cancer Ecosystem

    Assistant Professor and Junior Group Leader Department of Tumor Biology and Immunology at the Netherlands Cancer Institute (NKI) in Amsterdam
    Leader of the Akkari Lab, Netherlands Cancer Institute (NKI) in Amsterdam
    Junior Member of the Oncode Institute
  • Erika Pearce, Ph.D.

    Erika Pearce, Ph.D.

    March 13, 2025

    A Polyamine-mediated Posttranslational Modification Required for Macrophage Tissue Residency 

    Bloomberg Distinguished Professor
    Professor of Oncology, Johns Hopkins University School of Medicine
    Co-Director, Cancer Immunology Program

    This seminar was not recorded. 
  • De’Broski R. Herbert Ph.D.

    De’Broski R. Herbert Ph.D.

    February 13, 2025 - CANCELED

    Myeloid-derived IL-33 drives itchy immunity

    Penn Presidential Professor of Immunology, Co-director of Admissions Immunology Graduate Group, Director of International Affairs and Outreach, Institute for Infection and Zoonotic Disease (IIZD), University of Pennsylvania, PennVet

    This seminar was canceled.
  • Simon T. Barry, PhD.

    Simon T. Barry, PhD.

    January 9, 2025

    Therapeutic targeting of myeloid cells

    Executive Director in Early Oncology at AstraZeneca, Cambridge, UK
  • Susan Kaech, PhD

    Susan Kaech, PhD

    Metabolic co-option of tissue resident macrophages in lung cancer

    December 12, 2024


    Professor and Director, NOMIS Center for Immunobiology and Microbial Pathogenesis, NOMIS Chair, Salk Institute for Biological Studies
  • Max Krummel,PhD

    Max Krummel,PhD

    Immune Archetypes in Cancer, focused through the lens of Myeloid Biology

    October 10, 2024

    Professor Department of Pathology, University of California San Francisco, USA
  • Christine Moussion,PhD

    Christine Moussion,PhD

    Tumor microenvironment and myeloid cells in Cancer Immunotherapy

    September 12, 2024Senior Principal Scientist - Group Leader, Tumor Microenvironment Strategy Lead, Cancer Immunology Discovery, Genentech
  • Clayton C. Yates, PhD

    Clayton C. Yates, PhD

    Reassessing tumor biology through the lens of Ancestry and Health Equity

    August 8, 2024

    John R. Lewis Professor of Pathology, Professor of Pathology, Oncology, Urologic-Oncology, Director for Translational Health Disparities and Global Health Equity Research, Program Co-Leader for Cancer Genetics and Epigenetics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD USA
  • Eric Ahrens, PhD

    Eric Ahrens, PhD

    In vivo imaging of myeloid cells using MRI and PET

    July 11, 2024

    Professor of Radiology at UC San Diego, San Diego County, California, United States
  • Daniela Quail, PhD

    Daniela Quail, PhD

    Fuelling cancer through obesity-associated inflammation

    June 13, 2024

    Assistant Professor, Rosalind and Morris Goodman Cancer Centre and the Department of Physiology, McGill University, Montréal, Québec, Canada

    This seminar talk was not recorded.

  • Nir Hacohen, PhD

    Nir Hacohen, PhD

    Myeloid cells in severe infections

    May 9, 2024

    Director of the Center for Cancer Immunology at Massachusetts General Hospital, Co-Director of the Center for Cell Circuits at the Broad Institute of MIT and Harvard. and the David P. Ryan Professor of Medicine at Harvard Medical School.

    This seminar talk was not recorded.
  • Marco Colonna, MD

    Marco Colonna, MD

    TREM and LILR Receptors in Neurodegeneration and Cancer

    March 14, 2024 

    Robert Rock Belliveau Professor, Pathology and Immunology, Washington University School of Medicine in St. Louis

     
  • Ira Mellman, PhD

    Ira Mellman, PhD

    The essential role of myeloid cells and the TME in controlling T cell immunity in cancer

    February 8, 2024

    Vice President of Research Oncology and Cancer Immunology, Genentech, USA
  • Robert Vonderheide, MD, DPhil

    Robert Vonderheide, MD, DPhil

    PST CD40 agonists and impact on myeloid cells in cancer

    January 11, 2024

    Director of the Abramson Cancer Center, John H. Glick Abramson Cancer Center Professor, University of Pennsylvania, USA
  • Tyler Miller, MD, PhD

    Tyler Miller, MD, PhD

    A new framework for understanding immunomodulatory myeloid cells in glioma (and other solid tumors)

    December 14, 2023Research Fellow, Department of Pathology Massachusetts General Hospital and Department of Cancer Biology Dana Farber Cancer Institute, USA